LAURA JOCHEN: Open Payments
NPI 1992586101 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,717 in 88 payments from 17 companies in 2025. Trend: 2023 $102 · 2024 $2,026 · 2025 $1,717
Food & beverage: $1,682Consulting: $24Education: $11
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $281 |
| GENZYME CORPORATION | 11 | $237 |
| AstraZeneca Pharmaceuticals LP | 5 | $219 |
| Regeneron Healthcare Solutions, Inc. | 12 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $143 |
| CSL Behring | 4 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $81 |
| BioCryst US Sales Co., LLC | 4 | $81 |
| Viatris Specialty LLC | 3 | $55 |
Products named: DUPIXENT, NUCALA, AIRSUPRA, TRELEGY ELLIPTA, CUVITRU, NEFFY, ORLADEYO, Hizentra.
Industry payments across AZ — which companies pay providers there.
